ArticleEvaluation of Circulating Serum Meteorin-like Protein Levels in Obesity and Type 2 Diabetes Mellitus
ArticleEvaluation of Circulating Serum Meteorin-like Protein Levels in Obesity and Type 2 Diabetes Mellitus
ArticleStudy of interleukin-18 ( IL18 ) and high sensitive C - reactive protein ( CRP ) in type 2 diabetes ( T2D ) with or without obesity
ArticleStudy of interleukin-18 ( IL18 ) and high sensitive C - reactive protein ( CRP ) in type 2 diabetes ( T2D ) with or without obesity
ArticleAssessment of Neuropeptides B & W, Leptin and Adiponectin in Children and Adolescents with Type 1 Diabetes Mellitus
ArticleAssessment of Neuropeptides B & W, Leptin and Adiponectin in Children and Adolescents with Type 1 Diabetes Mellitus
ArticleThe Association between Resistin, Leptin and Adiponectin with Obesity and Type 2 Diabetes Mellitus
ArticleThe Association between Resistin, Leptin and Adiponectin with Obesity and Type 2 Diabetes Mellitus
ArticleStudy of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy
ArticleStudy of Serum Omentin-1 and IL-6 in Patients with Obesity, Hypertension and Hypertensive Nephropathy
ArticleAssessment of Serum Concentrations of Omentin-1 in Children with Type 1 Diabetes as Indicator of Insulin Resistance
ArticleAssessment of Serum Concentrations of Omentin-1 in Children with Type 1 Diabetes as Indicator of Insulin Resistance
ArticleAssessment of Serum and Urinary Adiponectin as Biomarkers in Type 2 Diabetic Patients with Diabetic Nephropathy
ArticleAssessment of Serum and Urinary Adiponectin as Biomarkers in Type 2 Diabetic Patients with Diabetic Nephropathy
ArticleEffect of Adiposity on Plasma Visfatin and Retinol Binding Protein-4 with and without Type 2 Diabetes Mellitus
ArticleEffect of Adiposity on Plasma Visfatin and Retinol Binding Protein-4 with and without Type 2 Diabetes Mellitus
ArticleCirculating Adipocyte Fatty Acid Binding Protein (A-FABP): Predictor of Metabolic Syndrome in Patients with Type 2DM
ArticleCirculating Adipocyte Fatty Acid Binding Protein (A-FABP): Predictor of Metabolic Syndrome in Patients with Type 2DM